Cary Street Partners Investment Advisory’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.3K | Hold |
245
| – | – | 0.01% | 482 |
|
|
2025
Q1 | $19.9K | Hold |
245
| – | – | 0.01% | 444 |
|
|
2024
Q4 | $22.1K | Buy |
+245
| New | +$22.1K | 0.01% | 400 |
|
|
2024
Q3 | – | Sell |
-5,182
| Closed | -$480K | – | 791 |
|
|
2024
Q2 | $480K | Sell |
5,182
-863
| -14% | -$80K | 0.02% | 480 |
|
|
2024
Q1 | $574K | Buy |
+6,045
| New | +$574K | 0.02% | 432 |
|
|
2023
Q4 | – | Sell |
-800
| Closed | -$58.4K | – | 1800 |
|
|
2023
Q3 | $58.4K | Sell |
800
-25
| -3% | -$1.83K | ﹤0.01% | 823 |
|
|
2023
Q2 | $68.6K | Hold |
825
| – | – | ﹤0.01% | 743 |
|
|
2023
Q1 | $62.9K | Hold |
825
| – | – | ﹤0.01% | 688 |
|
|
2022
Q4 | $68.5K | Buy |
+825
| New | +$68.5K | 0.01% | 667 |
|
|
2020
Q4 | – | Sell |
-971
| Closed | -$108K | – | 886 |
|
|
2020
Q3 | $108K | Buy |
+971
| New | +$108K | 0.02% | 363 |
|